Rankings
▼
Calendar
HRMY Q1 2024 Earnings — Harmony Biosciences Holdings, Inc. Revenue & Financial Results | Market Cap Arena
HRMY
Harmony Biosciences Holdings, Inc.
$2B
Q1 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$155M
+29.8% YoY
Gross Profit
$127M
82.2% margin
Operating Income
$52M
33.7% margin
Net Income
$38M
24.8% margin
EPS (Diluted)
$0.67
QoQ Revenue Growth
-8.2%
Cash Flow
Operating Cash Flow
$31M
Free Cash Flow
$31M
Stock-Based Comp.
$10M
Balance Sheet
Total Assets
$847M
Total Liabilities
$332M
Stockholders' Equity
$515M
Cash & Equivalents
$333M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$155M
$119M
+29.8%
Gross Profit
$127M
$98M
+29.3%
Operating Income
$52M
$40M
+28.7%
Net Income
$38M
$29M
+30.0%
← FY 2024
All Quarters
Q2 2024 →